Breaking News Instant updates and real-time market news.

VZ

Verizon

$49.53

0.32 (0.65%)

, UNP

Union Pacific

$112.99

0.98 (0.87%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Friday in Verizon (VZ), Union Pacific (UNP), Sprint (S), PayPal (PYPL), CenturyLink (CTL), Norfolk Southern (NSC), FireEye (FEYE), TD Ameritrade (AMTD), Prudential (PRU), and Avon Products (AVP).

VZ

Verizon

$49.53

0.32 (0.65%)

UNP

Union Pacific

$112.99

0.98 (0.87%)

S

Sprint

$6.93

-0.14 (-1.98%)

PYPL

PayPal

$70.97

3.72 (5.53%)

CTL

CenturyLink

$19.04

0.55 (2.97%)

NSC

Norfolk Southern

$132.75

2.51 (1.93%)

FEYE

FireEye

$16.81

-0.01 (-0.06%)

AMTD

TD Ameritrade

$48.27

0.88 (1.86%)

PRU

Prudential

$110.78

1.18 (1.08%)

AVP

Avon Products

$2.28

0.02 (0.88%)

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 07

    Nov

  • 07

    Nov

  • 15

    Nov

  • 29

    Nov

  • 07

    Dec

VZ Verizon
$49.53

0.32 (0.65%)

10/16/17
10/16/17
DOWNGRADE

Perform
Crown Castle downgraded to Perform at Oppenheimer
As previously reported, Oppenheimer analyst Timothy Horan downgraded Crown Castle (CCI) to Perform from Outperform saying that recent reports denote a T-Mobile (TMUS)/Sprint (S) merger is imminent, and as it represents 40% of revenues and will be aggressively slashing supplier spending, which will offset growth in 600 MHz, FirstNet, 5G. The analyst sees a 70% probability of the deal receiving approval with major concessions and likely also attacking the wireline market and better able to compete with Verizon (VZ)/AT&T (T) on coverage/capacity.
09/20/17
OPCO
09/20/17
NO CHANGE
OPCO
Perform
Oppenheimer expects Sprint, T-Mobile merger to happen
Oppenheimer analyst Timothy Horan expect T-Mobile (TMUS) to merge with Sprint (S) in a stock-for-stock transaction at a $10 per share Sprint valuation. A T-Mobile/Sprint will be a better competitor to Verizon (VZ)/AT&T (T), the analyst says, adding that while the process is likely to have a few bumps and require time, he expects a merger to happen. Horan reiterates a Perform rating on Sprint's shares.
09/20/17
DBAB
09/20/17
NO CHANGE
DBAB
Sprint, T-Mobile merger unlikely to get regulatory approval, says Deutsche Bank
Deutsche Bank analyst Matthew Niknam continues to believe a potential merger between Sprint (S) and T-Mobile (TMUS) faces "significant hurdles" and is ultimately unlikely to get past regulatory concerns. Merits of the deal, however, are "unparalleled, and very tough to debate," Niknam tells investors in a research note following CNBC's report of progressing deal talks. He believes derivative stock reactions on the news, namely strength in AT&T (T) and Verizon (VZ) and weakness in the tower names, could be at risk of reversing. Among the towers, the analyst has Buy ratings on American Tower (AMT) and Crown Castle (CCI).
10/19/17
SBSH
10/19/17
NO CHANGE
Target $55
SBSH
Buy
Verizon shares to move up near-term on Q3 results, says Citi
Citi analyst Michael Rollins views this morning's Q3 results from Verizon Communications as positive citing the postpaid phone gains and recovering wireless service revenue. The quarter affirms the company's opportunity to improve the trajectory of wireless service revenue over the next 12 months while generating solid cash flow, Rollins tells investors in a post-earnings research note. The analyst expects Verizon shares to trade higher near-term on the back of these results. He keeps a Buy rating on the name with a $55 price target. Rollins notes Verizon's capex of $4.3B was just below his $4.4B forecast. Capex is now expected to be $16.8B, below the analyst's estimate of $17.0B.
UNP Union Pacific
$112.99

0.98 (0.87%)

10/04/17
SBSH
10/04/17
DOWNGRADE
SBSH
Neutral
Union Pacific downgraded to Neutral from Buy at Citi
Citi analyst Christian Wetherbee downgraded Union Pacific (UNP) to Neutral saying the Q3 rally in rail stocks has "pulled forward value." It is getting more challenging to see enough upside to broadly recommend names, Wetherbee tells investors in a research note. The analyst remains focused on Kansas City Southern (KSU) as his top pick. He keeps a $120 price target for shares of Union Pacific.
10/02/17
MSCO
10/02/17
DOWNGRADE
Target $100
MSCO
Equal Weight
Union Pacific downgraded on weaker auto, coal volumes at Morgan Stanley
As previously reported, Morgan Stanley analyst Ravi Shanker downgraded Union Pacific (UNP) to Equal Weight from Overweight, saying he believes it will likely "bear the brunt" of weaker auto and coal volumes into 2018. The analyst, who also downgraded CSX (CSX) to Underweight from Equal Weight this morning, said he believes volume growth will be incrementally harder for the rail sector in the second half and into 2018. Shanker cut his price target on Union Pacific to $100 from $102.
10/02/17
MSCO
10/02/17
DOWNGRADE
MSCO
Equal Weight
Union Pacific downgraded to Equal Weight from Overweight at Morgan Stanley
10/10/17
AGIS
10/10/17
DOWNGRADE
Target $122
AGIS
Hold
Union Pacific downgraded to Hold from Buy at Aegis
Aegis analyst Jeffrey Kauffman downgraded Union Pacific to Hold from Buy citing valuation, noting that its outlook deteriorates about 2% in both 2017 and 2018 in his view given that volumes have been more challenged in the coal and automotive markets and grain comparisons get tougher. However, given higher market valuations, he has raised his price target on the stock to $122 from $120.
S Sprint
$6.93

-0.14 (-1.98%)

10/18/17
WELS
10/18/17
NO CHANGE
WELS
Wells Fargo 'surprised' tower stocks didn't react to SoftBank news
After it was reported that SoftBank (SFTBF) and Australian real estate company Lendlease formed a joint venture to purchase 8,000 cell tower sites in the U.S., Wells Fargo analyst Jennifer Fritzsche said she was "surprised" that tower company stocks did not react to this news. She had already thought if a T-Mobile (TMUS) and Sprint (S) merger deal was followed by T-Mobile CTO Neville Ray talking about network savings that the tower stocks "could take a hit," and this news may have given him "a much bigger arrow" in that quiver, she tells investors. Publicly traded tower companies include American Tower (AMT), Crown Castle (CCI) and SBA (SBAC).
10/19/17
10/19/17
DOWNGRADE
Target $8

Neutral
Sprint downgraded to Neutral on minmal deal premium at Macquarie
As previously reported, Macquarie downgraded Sprint (T) to Neutral from Outperform with an $8 price target. Analyst Amy Young said a T-Mobile (TMUS) merger with Sprint could be imminent, but preliminary deal terms are not as attractive as she initially expected, especially speculation SoftBank may be willing to accept market price in an all-equity deal. Young sees Sprint upside as limited and the competitive landscape picking up into 2018 with the current iPhone cycle.
10/18/17
MACQ
10/18/17
DOWNGRADE
MACQ
Neutral
Sprint downgraded to Neutral from Outperform at Macquarie
10/19/17
10/19/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Neutral from Buy at Goldman Sachs with analyst Lindsay Drucker Mann saying shares will trade in a range as Nike works through excess inventory in the U.S. and next week's investor day is unlikely to be a positive catalyst. 2. Sprint (S) downgraded to Neutral from Outperform at Macquarie with analyst Amy Young saying a T-Mobile (TMUS) merger with Sprint could be imminent, but preliminary deal terms are not as attractive as she initially expected, especially speculation SoftBank (SFTBY) may be willing to accept market price in an all-equity deal. 3. Hain Celestial (HAIN) downgraded to Market Perform from Outperform at BMO Capital with analyst Amit Sharma saying valuation reflects a challenging operating environment. 4. Allergan (AGN) downgraded to Neutral from Buy at Mizuho. 5. MAA (MAA) downgraded to Market Perform from Outperform at JMP Securities with analyst Aaron Hecht saying shares are fairly valued as they approach his previous price target of $110. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PYPL PayPal
$70.97

3.72 (5.53%)

10/20/17
RBCM
10/20/17
NO CHANGE
Target $83
RBCM
Outperform
PayPal price target raised to $83 from $65 at RBC Capital
RBC Capital analyst Daniel Perlin raised his price target on PayPal to $83 and maintained his Outperform rating following Q3 results. Perlin says the fundamentals on PayPal remain intact with total payment volume growth of 29%, account increase of 14%, and operating margin expansion of 150 basis points. Perlin says the valuation on PayPal should be modeled closer to tech and internet peers rather than payment networks with more mature business models.
10/20/17
BMOC
10/20/17
NO CHANGE
Target $80
BMOC
Outperform
PayPal price target raised to $80 from $70 at BMO Capital
BMO Capital analyst Paulo Ribeiro raised his price target on Paypal to $80 following Q3 results and kept his Outperform rating. Ribeiro noted accelerating momentum in new accounts and increased engagement helping EPS growth, along with expansion in products and services. The analyst also says the company's initial FY18 outlook suggests strength in mobile total payment volume and an encouraging rollout of Venmo monetization.
10/20/17
BARD
10/20/17
NO CHANGE
Target $80
BARD
Outperform
PayPal price target raised to $80 from $65 at Baird
Baird analyst Colin Sebastian raised his price target on PayPal to $80 citing strong Q3 results. He said it remains one of the best plays on e-commerce as the company continues to demonstrate accelerating growth across almost all key metrics including total payment volume, revenue, transaction growth, and net new customer additions. Sebastian reiterated his Outperform rating on PayPal shares.
10/20/17
RHCO
10/20/17
NO CHANGE
Target $75
RHCO
Hold
PayPal price target raised to $75 from $60 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target on PayPal to $75 following Q3 results, maintaining a Hold rating. Jeffrey says PayPal has a balanced risk-reward of at least a 15% P/E premium to the network and faces long-term competitive threats, taking a "guarded view toward sustainable Venmo monetization", though the company has done an impressive job to drive account growth and user engagement.
CTL CenturyLink
$19.04

0.55 (2.97%)

10/04/17
LEHM
10/04/17
NO CHANGE
Target $19
LEHM
Underweight
Barclays lowers price targets for CenturyLink, Level 3
Barclays analyst Amir Rozwadowski lowered his price target for Underweight-rated CenturyLink (CTL) to $19 from $23 and for Equal Weight-rated Level 3 Communications (LVLT) to $53 from $59. The combination of downward estimate revisions, management changes and a delay in the timing of merger close has heightened the perceived challenges facing the joint entity, Rozwadowski tells investors in a research note. The analyst, however, sees less downside potential for CenturyLink based on his new price target. He believes improved clarity on the joint entity's strategic priorities as well as the size and scope of synergy upside would "serve as a net benefit for helping the company recapture the narrative and provide a necessary realignment of investor expectations."
08/18/17
BOFA
08/18/17
NO CHANGE
Target $42
BOFA
Buy
CenturyLink and Level 3 deal moving forward, says BofA/Merrill
BofA/Merrill analyst David Barden said weakness in CenturyLink (CTL) appears related to reports that the regulatory timeline for the Level 3 (LVLT) merger could slip past the September 30 target date. Barden said Department of Justice timing remains on track but The California Public Utility Commission has a 60 day window to approve the deal. After 60 days, there is a potential lag of 30 days which would put the final approval timing in the first week of November, at the latest. Barden said a 5 week slippage is possible, but no delay is certain, and the regulatory time frame has zero bearing on the deal approval. Further, the analyst said some investors view Windstream's (WIN) surprise dividend cut as an indicator that CenturyLink may do the same post the Level 3 deal. Barden does not expect a cut and notes the company is not in the same position as Winstream and management stated it continues to pay its $2.16/share annual dividend and that the Level 3 acquisition improves the payout ratio. The analyst rates CenturyLink a Buy with a $42 price target.
08/23/17
MSCO
08/23/17
NO CHANGE
Target $26
MSCO
Overweight
CenturyLink, Uniti Group risk/reward attractive, says Morgan Stanley
Morgan Stanley analyst Simon Flannery is surprised by the magnitude of share declines for Overweight rated CenturyLink (CTL) and Uniti Group (UNIT) and continues to view risk/reward as attractive. Flannery said Q2 results showed cable continued to to drive consumer sub growth, reinforcing his view to own these two infrastructure assets that will benefit from growing business IP/mobile traffic. The analyst trimmed CenturyLink's price target to $26 from $27 and cut Uniti's to $24 from $32.
09/28/17
RAJA
09/28/17
NO CHANGE
RAJA
DOJ appointment catalyst for CenturyLink, Level 3 deal, says Raymond James
Makan Delrahim was finally confirmed by the Senate yesterday as head of the Department of Justice Antitrust Division, Raymond James analyst Frank Louthan tells investors in a research note. He believes not having an antitrust head is at least partially to blame for the delay in mergers and acquisitions in the Technology & Communications space this year, including outstanding transactions like CenturyLink (CTL)/Level 3 Communications (LVLT) and AT&T (T)/Time Warner (TWX), as well as potential deals like Sprint (S)/T-Mobile U.S. (TMUS). The appointment of Delrahim is a catalyst for the approval of CenturyLink's acquisition of Level 3, where the Department of Justice has been the bottleneck, Louthan writes.
NSC Norfolk Southern
$132.75

2.51 (1.93%)

10/12/17
FBCO
10/12/17
NO CHANGE
Target $143
FBCO
Outperform
Norfolk Southern price target raised to $143 from $133 at Credit Suisse
Credit Suisse analyst Allison Landry raised her price target for Norfolk Southern to $143 from $133 on valuation. The analyst reiterates an Outperform rating on the shares.
10/16/17
WELS
10/16/17
DOWNGRADE
WELS
Market Perform
CSX downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Matthew Troy downgraded both CSX (CSX) and Norfolk Southern (NSC) to Market Perform. Moderating carload growth in the second half of 2017 will weigh on results while the upside in the shares is appropriately valued at current levels, Troy tells investors in a research note. He believes the coal, agriculture and auto end markets "present significant headwinds" with comparisons growing more difficult. The analyst lowered his price target for CSX shares to $57 from $59.
10/16/17
WELS
10/16/17
DOWNGRADE
WELS
Market Perform
Norfolk Southern downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Matthew Troy downgraded both CSX (CSX) and Norfolk Southern (NSC) to Market Perform. Moderating carload growth in the second half of 2017 will weigh on results while the upside in the shares is appropriately valued at current levels, Troy tells investors in a research note. He believes the coal, agriculture and auto end markets "present significant headwinds" with comparisons growing more difficult. The analyst raised his price target for Norfolk Southern shares to $135 from $130.
10/17/17
COWN
10/17/17
NO CHANGE
COWN
Railroad estimates revised to reflect improving freight conditions at Cowen
Cowen analyst Jason Seidl revised his estimates following updated carloads, fuel, mix, and currency factors. The analyst said the revisions reflect the improving freight conditions especially in the trucking market, where tightening capacity is likely to be exacerbated by ELD implementation. He said Norfolk Southern (NSC) saw the only upward Q3 revision and remains his favorite rail while he lowered estimates for Canadian Pacific (CP) and CSX (CSX). He raised his price target on his Outperform rated names including Genesse & Wyoming (GWR) to $81 from $75, Norfolk Southern to $143 from $130, Canadian Pacific (CP) to $182 from $172, and Canadian National (CNI) to $87 from $83.
FEYE FireEye
$16.81

-0.01 (-0.06%)

09/18/17
STPT
09/18/17
DOWNGRADE
STPT
Hold
FireEye downgraded to Hold from Buy at Standpoint Research
09/25/17
BOFA
09/25/17
NO CHANGE
Target $21
BOFA
Buy
FireEye price target raised to $21 from $18 at BofA/Merrill
BofA/Merrill analyst Tal Liani raised Buy rated FireEye's price target to $21 from $18 to reflect progress on its turnaround, low expectations and industry momentum. The analyst sees significant upside to consensus estimates driven by new network hardware that can drive a customer refresh cycle and average deal size, lower coast cloud based solutions that can drive mid-market share, higher adoption of Helix, and anti-virus certification by quarter-end for its industry leading Enterprise detection and response solutions.
09/11/17
09/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. MasterCard (MA) upgraded to Buy from Neutral at Guggenheim. 2. FireEye (FEYE) upgraded to Overweight from Equal Weight at Stephens with analyst Jonathan Ruykhaver saying he believes consensus expectations are modeling a decline in product revenue this year, though he thinks this is too low given the refresh opportunity from appliance sales about 3 years ago. 3. Teva (TEVA) upgraded to Buy from Neutral at BTIG with analyst Timothy Chiang saying the company's appointment of Kare Schultz as its new CEO is "a positive catalyst that should help create a floor for the shares and provide a boost to near-term investor sentiment." 4. Incyte (INCY) upgraded to Outperform from Market Perform at Raymond James with analyst Reni Benjamin citing increased confidence in the probability of success of the ongoing Phase III ECHO-301, Epa plus pembrolizumab study, the commercial prospects of the Epa franchise in melanoma and at least four other tumor types, as well as the U.S. commercial opportunity for baricitinib. 5. QuickLogic (QUIK) upgraded to Buy from Neutral at Roth Capital with analyst Suji Desilva saying he believes its revenues are better positioned for upside revisions. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/18/17
STPT
09/18/17
DOWNGRADE
STPT
Hold
Follow-up: FireEye downgraded to Hold on valuation at Standpoint Research
As previously reported, Standpoint Research downgraded FireEye to Hold from Buy. Analyst Ronnie Moss said shares are up over 32% since his recommendation in January and are nearing his $18 price target.
AMTD TD Ameritrade
$48.27

0.88 (1.86%)

10/09/17
BOFA
10/09/17
DOWNGRADE
BOFA
Neutral
TD Ameritrade downgraded to Neutral on valuation and outlook at BofA/Merrill
As previously reported, BofA/Merrill downgraded TD Ameritrade to Buy from Neutral and increased its price target to $52 from $51. Analyst Michael Carrier said valuation has become elevated and sees limed upside as expectations for interest rates have increased, payment for order flow in back in the news, and there are lack of near-term catalysts following the Scottrade deal.
10/09/17
BOFA
10/09/17
DOWNGRADE
BOFA
Neutral
TD Ameritrade downgraded to Neutral from Buy at BofA/Merrill
10/06/17
RAJA
10/06/17
NO CHANGE
RAJA
Raymond James says buy Ameritrade and E-Trade on short-term weakness
Renewed concerns regarding the ability of online brokers to capture payment for order flow are not justified, Raymond James analyst Patrick O'Shaughnessy tells investors in an intraday research note. The Treasury Department's recently released report includes language that suggests downside risks for the brokers, but the topic itself is nothing new, nor are the proposed remedies, O'Shaughnessy argues. He points out that online brokerage firms are generally on board with these reforms. Further, the analyst believes the Massachusetts investigation into retail broker order routing decisions isn't likely to go anywhere. O'Shaughnessy recommends taking advantage of any short-term weakness in TD Ameritrade (AMTD) and E-Trade (ETFC). He has Outperform ratings on Ameritrade and E-Trade and a Market Perform rating on Charles Schwab (SCHW).
10/10/17
SBSH
10/10/17
INITIATION
Target $50
SBSH
Neutral
TD Ameritrade resumed with a Neutral at Citi
Citi analyst William Katz resumed coverage of TD Ameritrade with a Neutral rating and $50 price target.
PRU Prudential
$110.78

1.18 (1.08%)

10/18/17
GSCO
10/18/17
INITIATION
Target $114
GSCO
Neutral
Prudential initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Alex Scott started Prudential Financial with a Neutral rating and $114 price target while initiating coverage of the life insurance industry with a Neutral coverage view.
10/17/17
10/17/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Biogen (BIIB) upgraded to Buy from Neutral at Mizuho with analyst Thomas Shrader saying he likes what he sees at Biogen again. 2. Prudential (PRU) upgraded to Buy from Neutral at Citi with analyst Suneet Kamath saying Prudential's current valuation does not give the company enough credit for the quality of its business mix. 3. Chevron (CVX) upgraded to Outperform from Neutral at Macquarie with analyst Iain Reid saying cost reduction efforts and new production volumes driving outstanding free cash generation, which should cover capex and the dividend at an oil price below $40/bbl from 2018 onward. 4. Energy Transfer Equity (ETE) upgraded to Buy from Neutral at Goldman Sachs with analyst Theodore Durbin saying he expects Energy Transfer Equity's above average distribution growth to be driven by an improving free cash flow profile. 5. Emerson (EMR) was upgraded to Outperform from Market Perform at Cowen and to Buy from Neutral at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/17/17
SBSH
10/17/17
UPGRADE
Target $123
SBSH
Buy
Prudential upgraded to Buy from Neutral at Citi
Citi analyst Suneet Kamath upgraded Prudential (PRU) to Buy and raised his price target for the shares to $123 from $110. The analyst also reiterates a Sell rating on MetLife (MET) with an unchanged price target of $47. Prudential's current valuation does not give the company enough credit for the quality of its business mix, Kamath tells investors in a research note. He believes the shares are attractive post the year-to-date underperformance. The analyst also thinks investors will be underwhelmed by Metlife's earnings growth and return on equity post the Brighthouse Financial (BHF) separation.
10/10/17
10/10/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Prudential (PRU) upgraded to Buy from Neutral at FBR Capital. 2. RBS (RBS) was upgraded to Neutral from Sell at Citi and to Neutral from Underperform at Credit Suisse. 3. Palo Alto Networks (PANW) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Keith Weiss saying he sees building traction across the company's portfolio of solutions and he views it as one of the best positioned vendors to execute on an integrated security platform story. 4. Illinois Tool Works (ITW) upgraded to Neutral from Underweight at JPMorgan with analyst Ann Duignan saying organic growth is likely to be better than forecast in the third quarter. 5. McKesson (MCK) upgraded to Outperform from Market Perform at Cowen with analyst Charles Rhyee saying the transition towards differential specialty pricing will drive both earnings growth and multiple expansion. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AVP Avon Products
$2.28

0.02 (0.88%)

07/06/17
DADA
07/06/17
INITIATION
Target $4.25
DADA
Neutral
Avon Products initiated with a Neutral at DA Davidson
DA Davidson analyst Linda Bolton Weiser initiated Avon Products with a Neutral and a $4.25 price target saying she does not see a change in the "status quo" to drive valuation higher near-term.
09/13/17
JEFF
09/13/17
INITIATION
Target $2.2
JEFF
Underperform
Avon Products initiated with an Underperform at Jefferies
Jefferies analyst Stephanie Wissink started Avon Products with an Underperform rating and $2.20 price target. The analyst sees an "elongated period to drive improvement" amid management changes and a "yet to take hold" revival plan.
08/04/17
08/04/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fluor (FLR) was downgraded to Hold from Buy at Deutsche Bank and to Neutral from Buy at DA Davidson. 2. Teva (TEVA) was downgraded to Market Perform from Outperform at Cowen, to Neutral from Outperform at Credit Suisse, and to Underperform from Outperform at RBC Capital. 3. Ford (F) downgraded to Neutral from Buy at Nomura Instinet with analyst Anindya Das citing uncertainties surrounding North America and European growth. 4. Avon Products (AVP) downgraded to Hold from Buy at Deutsche Bank with analyst Faiza Alwy saying the Chief Executive Officer change suggests that a business recovery, should there be one, is more than 12 months away. 5. CommScope (COMM) was downgraded to Hold from Buy at Cross Research, to Neutral from Buy at Longbow, and to Equal Weight from Overweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/17
DBAB
08/04/17
DOWNGRADE
Target $3
DBAB
Hold
Avon Products downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Faiza Alwy downgraded Avon Products to Hold saying the CEO change suggests that a business recovery, should there be one, is more than 12 months away. To reflect lowered estimates following"another weak quarter" from Avon, the analyst cut her price target for the shares to $3 from $5. The stock closed yesterday down 11% to $3.00.

TODAY'S FREE FLY STORIES

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 06

    Dec

WGL

WGL Holdings

$84.32

-0.14 (-0.17%)

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Earnings
WGL Holdings reports Q4 adjusted EPS (17c), consensus (19c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

, LMOS

Lumos Networks

17:58
11/17/17
11/17
17:58
11/17/17
17:58
Hot Stocks
Tactile Systems to replace Lumos Networks in S&P 600 at open on 11/22 »

EQT Infrastructure…

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

, MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

17:56
11/17/17
11/17
17:56
11/17/17
17:56
Hot Stocks
Breaking Hot Stocks news story on Invesco Mortgage, MKS Instruments »

Invesco Mortgage to…

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

17:55
11/17/17
11/17
17:55
11/17/17
17:55
Hot Stocks
MKS Instruments to replace Brocade in S&P 400 at open on 11/22 »

S&P 500 constituent…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

UQM

UQM Technologies

$1.18

0.015 (1.29%)

17:24
11/17/17
11/17
17:24
11/17/17
17:24
Syndicate
Breaking Syndicate news story on UQM Technologies »

UQM Technologies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$238.02

-1.35 (-0.56%)

17:23
11/17/17
11/17
17:23
11/17/17
17:23
Periodicals
Goldman Sachs has $510M lawsuit dismissed, Reuters reports »

A $510M lawsuit that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICL

Vical

$1.94

-0.02 (-1.02%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Breaking Hot Stocks news story on Vical »

Biotechnology Value Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Ligand director sells 5,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CFO sells 6,559 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CEO sells 5,269 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBI

MBIA

$9.01

0.13 (1.46%)

17:15
11/17/17
11/17
17:15
11/17/17
17:15
Hot Stocks
Breaking Hot Stocks news story on MBIA »

Fine Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBCN

Rubicon

$8.07

0.1218 (1.53%)

17:03
11/17/17
11/17
17:03
11/17/17
17:03
Hot Stocks
Breaking Hot Stocks news story on Rubicon »

Bandera Partners reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANCB

Anchor Bancorp

$24.75

-0.1 (-0.40%)

17:02
11/17/17
11/17
17:02
11/17/17
17:02
Hot Stocks
Anchor Bancorp announces stock repurchase program, 10b5-1 trading plan »

Anchor Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIFI

Gulf Island Fabrication

$12.30

-0.1 (-0.81%)

16:58
11/17/17
11/17
16:58
11/17/17
16:58
Syndicate
Breaking Syndicate news story on Gulf Island Fabrication »

Gulf Island Fabrication…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPB

Mid Penn Bancorp

$31.09

0.59 (1.93%)

16:51
11/17/17
11/17
16:51
11/17/17
16:51
Hot Stocks
Mid Penn Bancorp, Scottdale shareholders approve merger »

Mid Penn Bancorp and The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CALD

Callidus Software

$28.95

0.3 (1.05%)

16:49
11/17/17
11/17
16:49
11/17/17
16:49
Initiation
Callidus Software initiated at First Analysis »

Callidus Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIFI

Gulf Island Fabrication

$12.30

-0.1 (-0.81%)

16:46
11/17/17
11/17
16:46
11/17/17
16:46
Hot Stocks
Breaking Hot Stocks news story on Gulf Island Fabrication »

Piton Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

16:42
11/17/17
11/17
16:42
11/17/17
16:42
Hot Stocks
General Electric CEO acquires 60,000 common shares »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRE

Northstar Realty Europe

$14.20

0.05 (0.35%)

16:33
11/17/17
11/17
16:33
11/17/17
16:33
Syndicate
Breaking Syndicate news story on Northstar Realty Europe »

Northstar Realty Europe…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

  • 30

    Nov

FHN

First Horizon

$18.40

0.1 (0.55%)

, CBF

Capital Bank

$39.95

0.25 (0.63%)

16:33
11/17/17
11/17
16:33
11/17/17
16:33
Hot Stocks
First Horizon, Capital Bank agree to sell two branches to Apex Bank »

First Horizon (FHN) and…

FHN

First Horizon

$18.40

0.1 (0.55%)

CBF

Capital Bank

$39.95

0.25 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$194.25

-0.75 (-0.38%)

16:32
11/17/17
11/17
16:32
11/17/17
16:32
Hot Stocks
Lennox executive sells 2,500 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

TBNK

Territorial Bancorp

$30.99

0.21 (0.68%)

16:31
11/17/17
11/17
16:31
11/17/17
16:31
Hot Stocks
Territorial Bancorp declares special cash dividend of 30c per share »

Payable on December 20.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRTN

Triton International

$40.07

-0.77 (-1.89%)

16:30
11/17/17
11/17
16:30
11/17/17
16:30
Hot Stocks
Triton International's Hanau sells 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
11/17/17
11/17
16:30
11/17/17
16:30
Options
Preliminary option volume of 21.1M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.